To Evaluate the Efficacy and Safety of QL1206 and Xgeva in Patients With Bone Metastases From Solid Tumors

NCT04550949 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

700

Enrollment

INDUSTRY

Sponsor class

Conditions

Bone Metastases

Interventions

DRUG: QL1206
DRUG: Xgeva

Sponsor

Qilu Pharmaceutical Co., Ltd.